Literature DB >> 8918685

Sequestration of centrally administered insulin by the brain: effects of starvation, aluminum, and TNF-alpha.

M F Cashion1, W A Banks, A J Kastin.   

Abstract

Insulin found in the CNS may be a key regulator in the balance of energy in the body. Since the peripheral circulation is the principal source of insulin in the CNS, insulin must cross the blood-brain barrier. We examined the retention of radioactively labeled insulin in the brain and its transport from the brain after injection icv in mice. The results were compared with those found in mice after fasting, starvation, refeeding, and the addition of aluminum (previously shown to affect the transport of peptides from the CNS) as well as tumor necrosis factor-alpha (TNF-alpha) (known to interact with peripheral insulin). There was no obvious saturable transport system for insulin from the brain, but the retention of insulin was regulated by both aluminum and starvation. Although TNF-alpha was neither required nor involved chronically in the retention of insulin in the brain, acute ip administration of TNF-alpha produced an early increase in the retention of insulin similar to that found after starvation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918685     DOI: 10.1006/hbeh.1996.0034

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  15 in total

Review 1.  Routes for the delivery of insulin to the central nervous system: A comparative review.

Authors:  Elizabeth M Rhea; Therese S Salameh; William A Banks
Journal:  Exp Neurol       Date:  2018-11-27       Impact factor: 5.330

2.  Transport of prion protein across the blood-brain barrier.

Authors:  W A Banks; Sandra M Robinson; R Diaz-Espinoza; A Urayama; C Soto
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

3.  Long-Term Intranasal Insulin Aspart: A Profile of Gene Expression, Memory, and Insulin Receptors in Aged F344 Rats.

Authors:  Hilaree N Frazier; Adam O Ghoweri; Emily Sudkamp; Eleanor S Johnson; Katie L Anderson; Grant Fox; Keomany Vatthanaphone; Mengfan Xia; Ruei-Lung Lin; Kendra E Hargis-Staggs; Nada M Porter; James R Pauly; Eric M Blalock; Olivier Thibault
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-05-22       Impact factor: 6.053

4.  Insulin transport across the blood-brain barrier can occur independently of the insulin receptor.

Authors:  Elizabeth M Rhea; Christian Rask-Madsen; William A Banks
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

5.  Intranasal Insulin Treatment Attenuates Metabolic Distress and Early Brain Injury After Subarachnoid Hemorrhage in Mice.

Authors:  Long-Biao Xu; Hua-Dong Huang; Ming Zhao; Guo-Chong Zhu; Zhen Xu
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

Review 6.  Insulin in the brain: there and back again.

Authors:  William A Banks; Joshua B Owen; Michelle A Erickson
Journal:  Pharmacol Ther       Date:  2012-07-17       Impact factor: 12.310

7.  Intranasal insulin treatment of an experimental model of moderate traumatic brain injury.

Authors:  Fiona Brabazon; Colin M Wilson; Shalini Jaiswal; John Reed; William H Frey; Kimberly R Byrnes
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-06       Impact factor: 6.200

8.  Brain insulin receptor causes activity-dependent current suppression in the olfactory bulb through multiple phosphorylation of Kv1.3.

Authors:  D A Fadool; K Tucker; J J Phillips; J A Simmen
Journal:  J Neurophysiol       Date:  2000-04       Impact factor: 2.714

Review 9.  ApoE and cerebral insulin: Trafficking, receptors, and resistance.

Authors:  Elizabeth M Rhea; Jacob Raber; William A Banks
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

10.  Nitric oxide isoenzymes regulate lipopolysaccharide-enhanced insulin transport across the blood-brain barrier.

Authors:  William A Banks; Shinya Dohgu; Jessica L Lynch; Melissa A Fleegal-DeMotta; Michelle A Erickson; Ryota Nakaoke; Than Q Vo
Journal:  Endocrinology       Date:  2008-01-10       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.